Panion & Bf Biotech Inc. (TPE:1760)

Taiwan · Delayed Price · Currency is TWD

56.00

-0.40 (-0.71%)

Sep 8, 2026, 1:30 PM CST

Market Cap	4.84B -23.0%
Revenue (ttm)	2.11B +5.0%
Net Income	214.83M +69.5%
EPS	2.50 +70.0%
Shares Out	85.74M
PE Ratio	22.56
Forward PE	n/a
Dividend	2.00 (3.57%)
Ex-Dividend Date	Jun 11, 2026

Volume	134,950
Open	56.40
Previous Close	56.40
Day's Range	55.70 - 56.40
52-Week Range	55.70 - 76.40
Beta	-0.11
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 12, 2026

About Panion & Bf Biotech

Panion & Bf Biotech Inc., a biotechnology pharmaceutical company, provides western medicines, cosmetics, testing reagents, food and chemical products in Taiwan, the United States, China, Hong Kong, Macau, and internationally. The company offers products in the areas of antibody, respiratory, gastrointestinal, COVID-19 IVD, antigen, anti-aging, active pharmaceutical ingredients, disease treatment, prevention, and veterinary products. It also offers nephrology, dermatology, pain management, hospital and household sanitization, and personal hygien... [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 1976

Country Taiwan

Stock Exchange Taiwan Stock Exchange

Ticker Symbol 1760

Full Company Profile

Financial Performance

In 2025, Panion & Bf Biotech's revenue was 2.06 billion, an increase of 1.66% compared to the previous year's 2.03 billion. Earnings were 190.17 million, an increase of 52.72%.

Financial Statements